封面
市場調查報告書
商品編碼
1138303

全球骨傳導助聽器市場-2022-2029

Global Bone Anchored Hearing Aids Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

人口老齡化和兒童聽力損失增加是市場增長的主要驅動力。

根據世界衛生組織的數據,大多數聽力損失的人都是成年人,尤其是 70 歲以上的人。大約 4.66 億人(佔世界人口的 5% 以上)患有聽力損失,其中約 4.32 億為成人,其餘 3400 萬為兒童。到 2050 年底,預計將有超過 9 億人患有聽力損失。超過 30% 的 65 歲以上的人患有聽力損失。世界老年人口也在顯著增長,導致聽力障礙的增加,進一步推動了對 BAHA 的需求。此外,兒童聽力障礙的增加也為這一人群的市場參與者提供了充足的機會。大約 11 億 12 至 35 歲的年輕人因在娛樂場所接觸噪音而面臨聽力損失的風險增加。

更多地採用機器人技術還可以顯著減少手術並發症,進一步增加產品需求。外科導航系統可改善耳外科醫生的視力並減少植入骨傳導助聽器時的人為錯誤。因此,市場供應商旨在開發增強型手術導航系統和機器人平台,以擴大產品消費。這些機器人系統的優勢可能會顯著提高他們對進行耳鼻喉手術的醫院和外科醫生的需求,從而在未來幾年擴大市場規模。人工耳蝸、助聽器和聽覺腦幹植入物等優質替代品預計將阻礙產品需求。

此外,產品副作用如皮膚刺激、骨整合失敗和慢性感染將進一步阻礙審查期間的市場增長。

全球骨傳導助聽器市場報告提供對大約 76 個市場數據表、58 個數字和 170 頁的訪問。

內容

第一章調查方法及範圍

  • 調查方法
  • 市場範圍

第 2 章主要趨勢和發展

第 3 章執行摘要

  • 按材料劃分的市場細分
  • 按聽力障礙類型劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
    • 約束因素
    • 商機
  • 影響分析

第五章行業分析

  • 波特五力分析
  • 價值鏈分析
  • 專利分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措

第 7 章材料

  • 陶瓷複合材料
  • 其他

第 8 章按聽力損失類型

  • 感覺神經性聽力損失
  • 傳導性聽力損失
  • 混合性聽力損失
  • 單耳聾

第 9 章,最終用戶

  • 兒科
  • 成人
  • 老年

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 競爭對手戰略分析
  • 市場情況/份額分析
  • 併購分析

第 12 章公司簡介

  • AUDITDATA
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Cochlear Limited
  • MED-EL Medical Electronics
  • Natus Medical Incorporated
  • Sivantos Group
  • Sonova Holding AG
  • Advanced Bionics Corporation
  • Phonak AG
  • Widex
  • Bernafon AG
  • Zhejiang Huangcheng Electronic Technology Co., Ltd.
  • Hunan Keyuan Medical Equipment Selling Co., Ltd.
  • Shenzhen Hearking Electronic Technology Co., Ltd.
  • Hunan Cofoe Medical Products Co., Ltd.
  • Zhongshan Huide Medical Co., Ltd.

第13章 DataM

簡介目錄
Product Code: DMHCIT2963

Market Overview

The Bone anchored hearing aids market was valued at USD 226.9 million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 7.89% during the forecast period (2022-2029).

A bone-anchored hearing aid (BAHA) is a surgical hearing device based on a conduction mechanism that helps patients suffering from hearing loss with vibrations. It is used to treat various hearing loss types, including single-sided deafness, chronic ear infections, and acoustic neuroma. Hearing losses mainly occur when sound is unable to reach the inner ear. In BAHA, a steel spring is attached over the person's head that gathers the sound waves as a traditional hearing aid, but instead of transmitting sound waves, it transfers vibrations to the inner ear through the skull bone. These hearing aids typically use a titanium alloy implant surgically implanted on the skull. The global bone anchored hearing aids market growth is mainly driven by the rising prevalence of hearing losses among the geriatric and pediatric populations globally, thus augments the industry expansion.

Market Dynamics: The increasing prevalence of hearing loss in the ageing and pediatric population is one of the prime factors proliferating the market growth.

According to World Health Organization, most people with hearing loss are adults, particularly those aged 70 years and above. More than 5% of the world's population, around 466 million people, has disabling hearing loss, of which about 432 million are adults and the remaining 34 million children. It is expected that by the end of 2050, more than 900 million people will suffer from disabling hearing loss. Over 30% of people over 65 are affected by disabling hearing loss. The global geriatric population is also growing significantly, increasing hearing impairment and further promulgating the demand for BAHA. Moreover, the growing prevalence of hearing impairment in children provides ample opportunities for the market players in this demography. Around 1.10 billion young people aged between 12-35 are at a high risk of hearing loss due to acquaintance with noise in recreational settings.

Moreover, the increased adoption of robotics can substantially reduce surgical complications, further driving product demand. The surgical navigation systems improve ear surgeons' visuals, resulting in lower human error while implanting bone-anchored hearing aids. Therefore, market suppliers aim to develop enhanced surgical navigation systems and robotic platforms to expand product consumption. These robotic systems' benefits will considerably bolster their demand among the hospitals and surgeons performing ENT treatments, thus proliferating the market expansion in the coming years. Good substitutes such as cochlear implants, hearing aids, and auditory brain stem implants are expected to hinder product demand.

Adversely, side effects of the product, such as skin irritation, failure of Osseo integration, and chronic infection, further hamper the market growth during the review period.

Market Segmentation: Titanium material segment accounted for the highest share in global bone anchored hearing aids market.

A bone-anchored hearing aid is a bone transmission hearing aid consisting of a titanium fixture permanently implanted into the skull's mastoid bone and an external percutaneous sound processor. The titanium-based implant is likely to last a lifetime. It is an ideal implant material. Medical-grade titanium exhibits unmatched strength when compared to other hearing aids. It can easily withstand more wear and tear as it won't crack or break, or get damaged easily. Besides, it is bio-acceptable with good hearing results. Moreover, it offers a better acoustic advantage due to its mechanical stiffness and low weight.

Based on the hearing loss type, the bone-anchored hearing aids market is classified into sensorineural hearing loss, mixed hearing loss, conductive hearing loss, and single-sided deafness. The conductive hearing loss end user is likely to garner the largest market share in the coming years. Conductive hearing loss is a prevalent type of hearing loss. Patients with this hearing impairment are generally fitted with either traditional air or bone conduction hearing aids. Although difficulties mainly arise when hearing loss is further complicated by chronic suppurative otitis media or otitis externa. In such situations, an ear mould is difficult to use. Some patients with bilateral conductive hearing losses who have complicating hearing issues such as canal atresia, mastoid cavities, or revision ossiculoplasty are crucial sources of frustration for all involved in their care. In these patients, the introduction of BAHA has been beneficial in helping with conductive hearing loss.

Based on end-user, the bone-anchored hearing aids market has been classified into pediatrics, adults, and geriatrics. The adult segment is anticipated to hold the largest market share in the bone-anchored hearing aids market during the review period. The adult segment is the major end-user of bone-anchored hearing aids due to the rising prevalence of hearing loss among adults worldwide.

Geographical Penetration: North America is the dominating region during the forecast period.

North America held the largest share in the global bone-anchored hearing aids market due to advanced and modern medical infrastructure & facilities coupled with high healthcare expenditure. Moreover, the easy availability of medical insurance and reimbursement facilities offered by Canada and the U.S. are expected to propel the demand for BAHA in the coming years. According to National Institute on deafness and other communication disorders, one in eight people in the U.S., around 13% or 30 million people aged 12 years and above, has hearing loss in both ears. Also, around 2% of adults aged 45 to 54 suffer from disabling hearing loss.

The European market is expected to account for a substantial market share in the following years due to an increasing inclination towards advanced hearing tools. Also, the prevalence of a large geriatric population in countries like Italy and Germany further drives the demand for BAHA. The presence of key vendors, growing awareness about the benefits of bone-anchored hearing aid prosthetics, and regulatory approvals augment European market growth. Vendors mainly focus on ramping up their sales in Western Europe through business strategies such as direct-to-consumer marketing and expanded field sales organization.

Competitive Landscape:

The bone-anchored hearing aids market is moderately competitive with the presence of regional and global players. Some key players contributing to the market's growth include AUDITDATA, Cochlear Limited, MED-EL Medical Electronics, Natus Medical Incorporated, Sivantos Group, Sonova Holding AG, and Advanced Bionics Corporation, among others. The major players are adopting several growth strategies, such as product launches, collaborations, and expansion, contributing to the growth of the bone-anchored hearing aids market globally. In March 2021, Cochlear Limited received FDA clearance for Baha 6 Max product. It is one of the smallest 55 dB sound processors with direct android streaming. Cochlear Limited is the global leader in implantable hearing solutions. This device has noise and feedback reduction features with a frequency range of 9.7 kHz. In March 2022, Sonova completes the acquisition of the Sennheiser Consumer Division and forms a new business. This acquisition creates growth opportunities in the fast-growing market for true wireless headsets, the emerging segment of speech-enhanced hearable, and expands Sennheiser's strong position in audiophile headphones. As part of the acquisition, the company has secured a perpetual license for the Sennheiser brand, under which all new consumer hearing devices are marketed.

COVID-19 Impact: Positive impact on the global bone anchored hearing aids market

COVID-19 has put considerable pressure on the healthcare and medical devices sector because of the increasing number of patients suffering from respiratory and other chronic diseases. The measures taken to reduce the coronavirus's spread during the pandemic have adversely affected patients' living conditions suffering from hearing loss without COVID-19 infection. The growing use of masks to curb coronavirus spread has led to decreased sound transmission and intelligibility. Besides, the lack of lip movements due to the facial mask is expected to increase the understanding of individuals with hearing impairment as these individuals highly depend on lip movements. Thus, these factors are mainly responsible for expanding hearing aids, such as bone-anchored hearing aids with hearing loss during the forecast timeline.

The global bone anchored hearing aids market report would provide an access to approximately 76 market data tables, 58 figures and 170 pages

Table of Contents

Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Material
  • 3.2. Market Snippet by Hearing Loss Type
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Material

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Material Segment
    • 7.1.2. Market attractiveness index, By Material Segment
  • 7.2. Titanium *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Ceramic composites
  • 7.4. Others

8. By Hearing Loss Type

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Hearing Loss Type Segment
    • 8.1.2. Market attractiveness index, By Hearing Loss Type Segment
  • 8.2. Sensorineural hearing loss*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Conductive hearing loss
  • 8.4. Mixed hearing loss
  • 8.5. Single-sided deafness

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By End User Segment
    • 9.1.2. Market attractiveness index, By End User Segment
  • 9.2. Pediatrics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Adult
  • 9.4. Geriatrics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key region-specific dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive scenario
  • 11.2. Competitor strategy analysis
  • 11.3. Market positioning/share analysis
  • 11.4. Mergers and acquisitions analysis

12. Company Profiles

  • 12.1. AUDITDATA*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cochlear Limited
  • 12.3. MED-EL Medical Electronics
  • 12.4. Natus Medical Incorporated
  • 12.5. Sivantos Group
  • 12.6. Sonova Holding AG
  • 12.7. Advanced Bionics Corporation
  • 12.8. Phonak AG
  • 12.9. Widex
  • 12.10. Bernafon AG
  • 12.11. Zhejiang Huangcheng Electronic Technology Co., Ltd.
  • 12.12. Hunan Keyuan Medical Equipment Selling Co., Ltd.
  • 12.13. Shenzhen Hearking Electronic Technology Co., Ltd.
  • 12.14. Hunan Cofoe Medical Products Co., Ltd.
  • 12.15. Zhongshan Huide Medical Co., Ltd.
  • List not Exhaustive*

13. DataM

  • 13.1. Appendix
  • 13.2. About us and services
  • 13.3. Contact us